Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis

S. Gräber (Heidelberg, Germany), C. Dopfer (Hannover, Germany), L. Naehrlich (Giessen, Germany), L. Gyulumyan (Hannover, Germany), H. Scheuermann (Heidelberg, Germany), S. Hirtz (Heidelberg, Germany), S. Wege (Heidelberg, Germany), H. Mairbaeurl (Heidelberg, Germany), M. Dorda (Hannover, Germany), R. Hyde (Hannover, Germany), A. Bagheri-Hanson (Giessen, Germany), C. Rueckes-Nilges (Giessen, Germany), S. Fischer (Hannover, Germany), M. Mall (Heidelberg, Germany), B. Tuemmler (Hannover, Germany)

Source: International Congress 2018 – Latest developments in cystic fibrosis
Session: Latest developments in cystic fibrosis
Session type: Poster Discussion
Number: 3415
Disease area: Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Gräber (Heidelberg, Germany), C. Dopfer (Hannover, Germany), L. Naehrlich (Giessen, Germany), L. Gyulumyan (Hannover, Germany), H. Scheuermann (Heidelberg, Germany), S. Hirtz (Heidelberg, Germany), S. Wege (Heidelberg, Germany), H. Mairbaeurl (Heidelberg, Germany), M. Dorda (Hannover, Germany), R. Hyde (Hannover, Germany), A. Bagheri-Hanson (Giessen, Germany), C. Rueckes-Nilges (Giessen, Germany), S. Fischer (Hannover, Germany), M. Mall (Heidelberg, Germany), B. Tuemmler (Hannover, Germany). Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis. 3415

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: